Clinical Effectiveness of Oral Semaglutide in Women with Type 2 Diabetes: A Nationwide, Multicentre, Retrospective, Observational Study (Women_ENDO2S-RWD Substudy)

Background: Sex differences in type 2 diabetes (T2D) are a growing area of diabetes research. No data have been reported on sex differences with oral semaglutide (oSEMA) in a real-world setting. Methods: We included people with T2D who started treatment with oSEMA in routine clinical practice betwee...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients 2025-07, Vol.17 (14), p.2349
Main Authors: Reyes-Garcia, Rebeca, Moreno-Pérez, Oscar, Guillen-Morote, Cristina, Modrego-Pardo, Inés, Doulatram-Gamgaram, Viyey Kishore, Casado Cases, Carlos, Arias Mendoza, Nieves, Tejera-Pérez, Cristina, Cárdenas-Salas, Jersy, Martínez-Fuster, Sandra, Lardiés-Sánchez, Beatriz, Márquez-Pardo, Rosa, Pinés, Pedro, Tejera-Muñoz, Antonio, Fernández-García, José Carlos
Format: Article
Language:English
Subjects:
Administration, Oral
Aged
Blood Glucose - drug effects
Blood pressure
Body mass index
Cardiovascular disease
Clinical outcomes
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Female
Gender differences
Glucagon-Like Peptide 1
Glucagon-Like Peptides - administration & dosage
Glucagon-Like Peptides - adverse effects
Glucagon-Like Peptides - therapeutic use
Glycated Hemoglobin - analysis
Glycosylated hemoglobin
Humans
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - adverse effects
Hypoglycemic Agents - therapeutic use
Male
Metabolism
Middle Aged
Observational studies
Patient compliance
Retrospective Studies
Sex discrimination
Sex Factors
Treatment Outcome
Type 2 diabetes
Weight Loss - drug effects
Womens health
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!